Showing results (111-120 of 362) with videos related to
Sort By:
Pageof 37
European Urology Focus|July 13, 2023
Long-term Recurrence Rates of Low-risk Non-muscle-invasive Bladder Cancer-How Long Is Cystoscopic Surveillance Necessary?Joshua Ma, Mathieu Roumiguie, Tetsutaro Hayashi, et al.Journal of Magnetic Resonance Imaging : JMRI|January 29, 2017
MR measurement of luminal water in prostate gland: Quantitative correlation between MRI and histologyShirin Sabouri, Ladan Fazli, Silvia D Chang, et al.Ultrasonics|October 3, 2025
Three-dimensional quantitative elastography using micro-ultrasound: Proof of conceptReid Vassallo, Tajwar Abrar Aleef, Qi Zeng, et al.Radiology|April 11, 2017
Luminal Water Imaging: A New MR Imaging T2 Mapping Technique for Prostate Cancer DiagnosisShirin Sabouri, Silvia D Chang, Richard Savdie, et al.Urologic Oncology|January 27, 2019
Editorial: Basic research in bladder cancer - refining the tools. 3rd IBCN seminars series1Peter C Black, Peter J Goebell, Ashish M Kamat, et al.NMR in Biomedicine|December 22, 2018
Comparing diagnostic accuracy of luminal water imaging with diffusion-weighted and dynamic contrast-enhanced MRI in prostate cancer: A quantitative MRI studyShirin Sabouri, Silvia D Chang, S Larry Goldenberg, et al.Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|August 4, 2020
Defining postoperative ileus and associated risk factors in patients undergoing radical cystectomy with an Enhanced Recovery After Surgery (ERAS) programConnor M Forbes, Ali Cyrus Chehroudi, Miles Mannas, et al.Cancer Treatment Reviews|August 21, 2018
Risk factors for loco-regional recurrence after radical cystectomy of muscle-invasive bladder cancer: A systematic-review and framework for adjuvant radiotherapyPaul Sargos, Brian C Baumann, Libni Eapen, et al.European Urology Oncology|September 24, 2020
Sex Differences in Bladder Cancer Immunobiology and Outcomes: A Collaborative Review with Implications for TreatmentMadhuri Koti, Molly A Ingersoll, Shilpa Gupta, et al.The Journal of Urology|April 18, 2007
Adenoviral mediated interferon-alpha 2b gene therapy suppresses the pro-angiogenic effect of vascular endothelial growth factor in superficial bladder cancerLiana Adam, Peter C Black, Wassim Kassouf, et al.Pageof 37